Balloon catheter procedure for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new balloon catheter that uses pulsed electric fields to treat persistent atrial fibrillation, a type of irregular heartbeat that lasts more than 7 days. The treatment aims to restore normal heart rhythm and may be an option for people who have not had prior heart procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have atrial fibrillation that has lasted continuously for at least 7 days but less than 2 years.
- You must be eligible for a standard heart procedure called catheter ablation, as per current guidelines.
- You must not have had any prior catheter ablation or heart surgery on the left side of the heart.
- You must not have certain other heart rhythm problems like atrial flutter or atrial tachycardia.
- You must not be pregnant, breastfeeding, or planning to become pregnant during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new balloon catheter that uses pulsed electric fields to isolate the veins that carry blood from your lungs to your heart. It may be a treatment option for people with atrial fibrillation who are scheduled for an ablation procedure.
This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.
This trial tests a new type of heart procedure called pulsed field ablation for people with persistent atrial fibrillation (a long-lasting irregular heartbeat). It compares three different ways to use this ablation to try to restore a normal heart rhythm and reduce symptoms.
This trial is testing a specific approach to catheter ablation for people with persistent atrial fibrillation. It aims to improve how abnormal heart tissue is targeted to help restore a normal rhythm.
This trial tests a balloon catheter that uses pulsed field energy to treat atrial fibrillation (AF) in people who have tried medication without success. It aims to see how well it works in real-world use.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.